Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
norenar07
norenar07 May. 13 at 3:17 PM
$HEPA they’ve scanned many folks over the years. They’ve changed their name many times. Have destroyed good folk’s portfolios that believed in the poo poo they were shoveling
0 · Reply
norenar07
norenar07 May. 13 at 3:13 PM
$HEPA same snake oil, different label
0 · Reply
Moneybucks
Moneybucks May. 12 at 7:26 PM
$HEPA Brancaccio sold Rencofilstat without a shareholder vote they stated it was their primary asset which under Delaware law would constitute substantially all of the companies assets Brancaccio thought by signing new day deal would be enough for him to steal Rencofilstat i don't think so it was even stated in quarter filings it was unlikely they would get anything from the deal so they wrote off the money they gave away what was it 525k dollars for absolutely nothing Brancaccio belongs in jail and Rencofilstat belongs back in hands of Hepion
0 · Reply
Moneybucks
Moneybucks May. 12 at 7:19 PM
$HEPA https://www.faegredrinker.com/en/insights/publications/2022/1/the-corporate-guide-is-a-stockholder-vote-necessary
0 · Reply
Moneybucks
Moneybucks May. 8 at 10:34 PM
$HEPA Patent published April 30th by HepQuant LLC looks like rencofilstat is a winner so nice of Brancaccio to give it away for nothing Vincent Lopriore needs to challenge the contract it should be voided their was no consideration paid for Rencofilstat
3 · Reply
prismmarketview
prismmarketview May. 7 at 4:35 PM
🚨 PRISM Mid-Day Movers 🚨 Pharmaceuticals and MedTech are leading today: Hepion Pharmaceuticals ( $HEPA ) +36% — speculative buying continues around the company’s cancer-diagnostics pivot story. Alpha Pro Tech ( $APT.X ) +26% — heavy volume sends the PPE and building-products name to new highs in a momentum-driven breakout. Other movers: 📈 Fluence ( $FLNC ) +23% 📈 NCR Voyix ( $VYX ) +17% 📉 GD Culture Group ( $GDC ) -85% #StockMarket #MarketMovers #Biotech #MedTech #MomentumTrading #SmallCaps #StocksToWatch https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-medtech-are-todays-leaders/
0 · Reply
Moneybucks
Moneybucks May. 6 at 5:10 PM
$HEPA https://hepionpharma.com/news/hepion-pharmaceuticals-executes-binding-letter-of-intent-with-new-day-diagnostics-to-commercialize-diagnostic-tests-for-celiac-disease-respiratory-multiplex-h-pylori-and-hcc/
1 · Reply
BADBOYROY
BADBOYROY May. 1 at 11:20 PM
$HEPA Canton Strategic Holdings Inc $CNTN why the sudden interest in Hepa?
0 · Reply
prismmarketview
prismmarketview Apr. 30 at 4:41 PM
PRISM Mid-Day Movers: Pharmaceuticals and Crypto Mining are Today’s Leaders. Hepion Pharmaceuticals, Inc. (OTC: $HEPA) is catching a speculative bid again, with shares up 31.24% at $0.071 after opening at $0.054. Abits Group Inc. (NASDAQ: $ABTS) is ripping higher midday, with shares at $1.3965, up 25.81% on the session as they trade between a day low of $1.21 and day high of $1.52. Other Notable Movers: Roadzen ( $RDZN) up 25% uniQure N.V., ( $QURE) up 19% Enveric Biosciences ( $ENVB)down -27% #PRISMMidDayMovers #Pharmaceuticals #CryptoMining #MicroCaps #OTCStocks #BitcoinMining #BiotechStocks #MarketMovers #MomentumTrading #HighVolatility #StocksToWatch #SmallCapStocks https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-crypto-mining-are-todays-leaders/
0 · Reply
justice_for_all
justice_for_all Apr. 29 at 5:55 AM
$HEPA = Romeo Must Die Workforce & Operations: As of Dec 31, 2025: 2 employees. Accumulated deficit: $246.1M (as of Dec 31, 2025). Hepion is now a near‑zero‑staff diagnostics licensing company. Bankruptcy is likely. Shareholders may receive little or no value.
1 · Reply
Latest News on HEPA
No data available.
norenar07
norenar07 May. 13 at 3:17 PM
$HEPA they’ve scanned many folks over the years. They’ve changed their name many times. Have destroyed good folk’s portfolios that believed in the poo poo they were shoveling
0 · Reply
norenar07
norenar07 May. 13 at 3:13 PM
$HEPA same snake oil, different label
0 · Reply
Moneybucks
Moneybucks May. 12 at 7:26 PM
$HEPA Brancaccio sold Rencofilstat without a shareholder vote they stated it was their primary asset which under Delaware law would constitute substantially all of the companies assets Brancaccio thought by signing new day deal would be enough for him to steal Rencofilstat i don't think so it was even stated in quarter filings it was unlikely they would get anything from the deal so they wrote off the money they gave away what was it 525k dollars for absolutely nothing Brancaccio belongs in jail and Rencofilstat belongs back in hands of Hepion
0 · Reply
Moneybucks
Moneybucks May. 12 at 7:19 PM
$HEPA https://www.faegredrinker.com/en/insights/publications/2022/1/the-corporate-guide-is-a-stockholder-vote-necessary
0 · Reply
Moneybucks
Moneybucks May. 8 at 10:34 PM
$HEPA Patent published April 30th by HepQuant LLC looks like rencofilstat is a winner so nice of Brancaccio to give it away for nothing Vincent Lopriore needs to challenge the contract it should be voided their was no consideration paid for Rencofilstat
3 · Reply
prismmarketview
prismmarketview May. 7 at 4:35 PM
🚨 PRISM Mid-Day Movers 🚨 Pharmaceuticals and MedTech are leading today: Hepion Pharmaceuticals ( $HEPA ) +36% — speculative buying continues around the company’s cancer-diagnostics pivot story. Alpha Pro Tech ( $APT.X ) +26% — heavy volume sends the PPE and building-products name to new highs in a momentum-driven breakout. Other movers: 📈 Fluence ( $FLNC ) +23% 📈 NCR Voyix ( $VYX ) +17% 📉 GD Culture Group ( $GDC ) -85% #StockMarket #MarketMovers #Biotech #MedTech #MomentumTrading #SmallCaps #StocksToWatch https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-medtech-are-todays-leaders/
0 · Reply
Moneybucks
Moneybucks May. 6 at 5:10 PM
$HEPA https://hepionpharma.com/news/hepion-pharmaceuticals-executes-binding-letter-of-intent-with-new-day-diagnostics-to-commercialize-diagnostic-tests-for-celiac-disease-respiratory-multiplex-h-pylori-and-hcc/
1 · Reply
BADBOYROY
BADBOYROY May. 1 at 11:20 PM
$HEPA Canton Strategic Holdings Inc $CNTN why the sudden interest in Hepa?
0 · Reply
prismmarketview
prismmarketview Apr. 30 at 4:41 PM
PRISM Mid-Day Movers: Pharmaceuticals and Crypto Mining are Today’s Leaders. Hepion Pharmaceuticals, Inc. (OTC: $HEPA) is catching a speculative bid again, with shares up 31.24% at $0.071 after opening at $0.054. Abits Group Inc. (NASDAQ: $ABTS) is ripping higher midday, with shares at $1.3965, up 25.81% on the session as they trade between a day low of $1.21 and day high of $1.52. Other Notable Movers: Roadzen ( $RDZN) up 25% uniQure N.V., ( $QURE) up 19% Enveric Biosciences ( $ENVB)down -27% #PRISMMidDayMovers #Pharmaceuticals #CryptoMining #MicroCaps #OTCStocks #BitcoinMining #BiotechStocks #MarketMovers #MomentumTrading #HighVolatility #StocksToWatch #SmallCapStocks https://prismmarketview.com/prism-mid-day-movers-pharmaceuticals-and-crypto-mining-are-todays-leaders/
0 · Reply
justice_for_all
justice_for_all Apr. 29 at 5:55 AM
$HEPA = Romeo Must Die Workforce & Operations: As of Dec 31, 2025: 2 employees. Accumulated deficit: $246.1M (as of Dec 31, 2025). Hepion is now a near‑zero‑staff diagnostics licensing company. Bankruptcy is likely. Shareholders may receive little or no value.
1 · Reply
jpurr
jpurr Apr. 28 at 9:01 PM
$HEPA The Gabe factor at play here too?
0 · Reply
justice_for_all
justice_for_all Apr. 28 at 5:03 PM
$HEPA HEPA is a zombie biotech — extremely distressed, heavily diluted, barely surviving, but not dead. It can continue limping along through micro‑financings, reverse splits, and filings, but the probability of long‑term recovery is extremely low without a major catalyst. IN OTHER WORDS = SCAM!
0 · Reply
prismmarketview
prismmarketview Apr. 27 at 4:15 PM
PRISM Mid-Day Movers: Pharmaceuticals and Weight Loss are Today’s Leaders. Shares of Hepion Pharmaceuticals, Inc. (OTC: $HEPA) are moving higher, with the stock up about 23% today to $0.0503 as very light absolute dollar flows translate into large percentage gains in this sub‑$1 million market‑cap name Shares of WW International, Inc. (Nasdaq: $WW) are ripping higher, trading at $11.32, up 22.11% on the day after opening at $9.60 and hitting an intraday high of $11.72 on volume of 781,313 shares versus an average of 313,427. Other Notable Movers: LifeVantage ( $LFVN) up 15% Momentus Inc. ( $MNTS) up 13% POET Technologies Inc., ( $POET) down -45% prismmarketview.com/prism-m...
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Apr. 27 at 12:30 PM
$HEPA CEO purchased 1,250,000 shares at $0.04 for a total of $50,000. Stetz Gary S. now owns 1,250,000 shares. https://ceo-buys.com
0 · Reply
aiolus
aiolus Apr. 23 at 1:00 PM
$HEPA Everyone should read HEPA’s latest filings carefully. In the 4/22/2026 8-K, Hepion says it sold 17,500,000 shares at $0.04 for total gross proceeds of $700,000 in a private placement. In the Form D for the same offering, the company reports: $700,000 total offering amount $700,000 sold 11 investors $0 sales commissions $0 finders’ fees. The part that stands out to me is Item 16 of the Form D. It says that $700,000 of the gross proceeds “has been or is proposed to be used for payments to” the persons named in Item 3, which lists company executives/directors. I am not claiming illegality, but if I am reading this correctly, this looks like very heavy dilution and the filing appears to say the proceeds were used or intended to be used for payments to insiders. Read the 8-K and Form D yourself and decide.
1 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:41 PM
$HEPA Massive dilution you fools holding onto shares😂
0 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:24 PM
$HEPA https://www.sec.gov/ix?doc=/Archives/edgar/data/0001583771/000149315226018575/form8-k.htm
0 · Reply
Opusone2010
Opusone2010 Apr. 16 at 10:51 PM
$HEPA 😂 this MC is lower than my investment property.. What a garbage dump!
0 · Reply
BADBOYROY
BADBOYROY Apr. 14 at 8:40 PM
$HEPA as Pharm calls her, ole Dr. Labia get $250,000 cash for literally doing nothing. What a way to live. https://s3.amazonaws.com/sec.irpass.cc/2652/0001493152-26-016557.htm
1 · Reply
prismmarketview
prismmarketview Mar. 30 at 4:35 PM
PRISM Mid-Day Movers: Healthcare and Aerospace & Defense are Today's Leaders. Bullfrog AI Holdings (NASDAQ: $BFRG) is ripping higher, up about 126% on a massive volume spike as this ultra‑low‑float, AI‑driven drug discovery micro‑cap becomes a momentum target in high‑risk territory. Astrotech (NASDAQ: $ASTC) is also soaring, recently up roughly 115–120% as heavy volume re‑rates the ultra‑thin micro‑cap off its lows despite a sub‑$10M market cap, negative EPS and a history of sharp volatility. Other Notable Movers: Iterum Therapeutics plc ($ITRM) up 75% Hepion Pharmaceuticals ( $HEPA) up 19% IceCure Medical ( $ICCM) down -22%
0 · Reply
beacher
beacher Mar. 26 at 11:57 AM
$HEPA Lucky I had a very small position here... I believe I will never see any money here😅
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 9:56 PM
$HEPA New executive office 34 Shrewbury ave suite 1D. 🤔 Their is a hot dog stand across the street😂 look it up im not joking😂
0 · Reply